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pathways could influence placebo effects, the incipient evidence being provided with regard to 
existence of genes that mediate placebo effects in individual patients. Placebo/nocebo genetics 
is an area in which research is only in a quit early phase.  
Conclusions. The study results evoke the complexity of the placebo and implicitly nocebo 
phenomena and the difficulty of formulating a generally valid theory, which could explain in a 
clear and complete manner how they function. The described mechanisms have to be regarded 
in a complementary manner and must be analyzed and regarded as a whole. It is worth to 
continue the investigations of placebo/nocebo mechanisms so as to optimize the therapeutic 
interventions and to improve the design of clinical trials.  
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Introduction. According to World Health Organization report, cardiovascular diseases are the 
leading cause of mortality, accounting for 31% worldwide. Cardiac ischemia is the key-
mechanism that underlies acute coronary syndrome and induces cellular necrosis. Prolonged 
ischemia and hypoxia switch the myocardial metabolism from aerobic to anaerobic glucose 
degradation with increased lactate formation. The accumulation of lactate in cardiac myocytes 
results in acidosis, altered energy metabolism and cellular membrane damage. We suppose that 
myocardial ischemia could cause an elevation of circulating lactate level.  
Aim of the study. The research purpose was to evaluate serum lactate levels in experimental 
acute myocardial infarction.  
Materials and methods. Forty healthy adult male rats were randomly divided into five groups: 
(L1) - sham; (L2) - control NaCl 0.9% solution; and with acute myocardial infarction induced 
by subcutaneous injection of isoproterenol hydrochloride 100 mg/ kg (one dose), and sacrificed 
after 6 h (L3), 24 h (L4) and 7 days (L5) respectively. Serum lactate concentration was 
determined using standard kit (ELITech, France). Obtained data were represented by median 
and interquartile range. For group comparison, the Kruskal-Wallis and Dunn nonparametric 
tests were performed (SPSS 23.0). 
Results. The investigated groups have shown statistically insignificant difference for serum 
levels of lactate (p < 0.05). Initially in L3 was identified a slight decrease, followed by a 
significant increase in L4, with a repeated fall in L5 group. 
Conclusions.  The obtained data denote the possible release of lactate from the ischemic 
cardiomyocytes to the blood. Serum lactate level, following acute myocardial infarction is a 
useful biomarker that reflects the severity of tissue hypoxia. 
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